Arbutus Biopharma
ABUS
$2.71
Share price
1.12%
Change (1 day)
6.27%
Change (1 year)
Categories
Arbutus Biopharma (ABUS) - Cash on Hand
Cash on Hand as of December 2023 : $0.12 B
According to Arbutus Biopharma
's latest financial reports the company has $0.12 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Arbutus Biopharma - Cash on Hand chart (from 2007 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.12 B | -14.23% |
| 2022-12-31 | $0.14 B | -5.41% |
| 2021-12-31 | $0.15 B | 26% |
| 2020-12-31 | $0.12 B | 35.71% |
| 2019-12-31 | $90.83 M | -27.11% |
| 2018-12-31 | $0.12 B | -1.37% |
| 2017-12-31 | $0.12 B | -3.22% |
| 2016-12-31 | $0.13 B | -27.99% |
| 2015-12-31 | $0.18 B | 61.65% |
| 2014-12-31 | $0.11 B | 63.22% |
| 2013-12-31 | $68.71 M | 46.13% |
| 2012-12-31 | $47.02 M | 422.77% |
| 2011-12-31 | $8.99 M | -27.13% |
| 2010-12-31 | $12.34 M | -47.02% |
| 2009-12-31 | $23.3 M | -11.24% |
| 2008-12-31 | $26.25 M | 24.24% |
| 2007-12-31 | $21.13 M | 334.33% |
| 2006-12-31 | $4.86 M | -53.58% |
| 2005-12-31 | $10.48 M | -58.06% |
| 2004-12-31 | $24.99 M | -36.25% |
| 2003-12-31 | $39.2 M | 2.71% |
| 2002-12-31 | $38.17 M | -19.74% |
| 2001-12-31 | $47.56 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.13 M | -99.90% | Bahamas |
 NRC Health
NRC | $6.65 M | -94.72% | 🇺🇸 USA |